Stroke Prevention in Patients With Atrial Fibrillation: Clinical Trials

4 trials for Stroke Prevention in Patients With Atrial Fibrillation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 not yet recruiting, 1 terminated. 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1
Phase 21Terminated 1

Follow Stroke Prevention in Patients With Atrial Fibrillation: new trials by email Literature Review of Stroke Prevention in Patients With Atrial Fibrillation trials Research Report on Stroke Prevention in Patients With Atrial Fibrillation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Left Atrial Appendage Occlusion in Dialysis Patients With Atrial Fibrillation: A Multicentre Pilot Study
Dialysis, Chronic Kidney Disease (Stages 3b-5)
Not yet recruitingPrince of Wales Hospital, Shatin, Hong Kong402026-12-052026-09-16
OPTION-EMEA Clinical Trial
Concomitant pulsed field ablation (PFA) and left atrial appendage closure (LAAC) during one interventional case, Concomitant Pulsed Field Ablation and Left Atrial Appendage Closure - Atrial Fibrillation (AF), Stroke Prevention in Patients With Atrial Fibrillation
Not applicableRecruitingBoston Scientific Corporation5002026-06-182026-10-27
CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke Prevention
Left Atrial Appendage Closure, Apixaban 2.5 mg BID, Standard-dose DOAC - Atrial Fibrillation, Stroke Prevention in Patients With Atrial Fibrillation
RecruitingNational Medical Research Center for Therapy and Preventive Medicine4642026-04-012026-05-08
Long Term Open Follow-up With H376/95 vs. Warfarin
EXANTA - Stroke Prevention in Patients With Atrial Fibrillation
Phase 2TerminatedAstraZeneca2201999-08-012010-11-15

Narrower conditions

Atrial Fibrillation (3)  ·  Hemorrhage (1)  ·  Renal Insufficiency, Chronic (1)  ·  Thromboembolism (1)

Broader conditions

Arrhythmias, Cardiac (3)  ·  Cardiovascular Diseases (3)  ·  Heart Diseases (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Embolism and Thrombosis (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Renal Insufficiency (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

Left Atrial Appendage Closure (2)  ·  BID protein, human (1)  ·  N(4)-oleylcytosine arabinoside (1)  ·  apixaban (1)  ·  ximelagatran (1)

Sponsors

AstraZeneca (1)  ·  Boston Scientific Corporation (1)  ·  National Medical Research Center for Therapy and Preventive Medicine (1)  ·  Prince of Wales Hospital, Shatin, Hong Kong (1)

Countries

Belgium (2)  ·  Croatia (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Finland (1)  ·  France (1)  ·  Hong Kong (1)  ·  Italy (1)  ·  Norway (1)  ·  Poland (1)  ·  Russia (1)  ·  Spain (1)  ·  Sweden (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Karapet Davtyan, Professor (1)  ·  Kent Chak Yu So, Clinical Assistant Professor (1)